1Development trend analysis of Chinese traditional medicine fermentation technology based on patent informationSUN Qing-shan, WEI Zi-qi, MA Yi-wen1905-19142Global approved new drugs in 2024:retrospect and prospectYANG Zhen-zheng, WANG Zi-han, WANG Yun, SUN You-song, CHEN Qian, ZHENG Lu-feng1915-19223Research on drug registration management of small and medium sized pharmaceutical enterprises in China based on SWOT analysisLI Xia, TIAN Li-juan1923-19304Considerations for the national specifications for low molecular weight heparin drugsYANG Xi, ZHOU Yi, LI Hui-yi1931-19355Impact of external technology acquisition on the innovation performance of bio-pharmaceutical industryZHAO Yan-lin, YANG Li1936-19436Advances in the application of monocyte activation test assay in the detection of pyrogensLIU Si-hua, FANG Yu, HONG Qi-hao, YAN Wen-hui, SU Gui-min, DU Lin1944-19517Research progress in preparation and evaluation of Chinese herbal volatile oil emulsionsYAN Bo, HOU Xiao-ying, ZHANG Nan, HAN Xue-mei, ZHAO Qing, WU Guo-tai1952-19598Research progress in aryl hydrocarbon receptor-related signaling regulatory pathways and their association with diseasesLI Hui-min, ZHANG Hong, WU Yan-lin1960-19669Real-world study of inclisiran vs PCSK9 monoclonal antibodies in patients with acute coronary syndromeLI Ting-ting, WANG Lin, LUO Wei, XU Jing-han, CONG Hong-liang1967-197310Correlation between quantity-quality changes of characteristic components in different ratios of Salviae Miltiorrhizae Radix et Rhizoma-Epimedii FoliumQI Yu-tong, MENG Shuo, PENG Qing, LIN Li, REN Jun-guo, ZHANG Miao, LIU Jian-xun1974-198411Exploring the mechanisms of the protective effect of Desmodium styracifolium(Osb.)Merr on cholestatic liver disease based on network pharmacology and in vitro experimentsZHI Yue-ping, ZHANG Ke-feng, TANG Zi-xuan, ZHANG Zhi-yuan, GAO Ya, CAO Hou-kang1985-199612Study on container closure integrity of packaging system of glycerin fructose sodium chloride injection by mass extraction methodGUO Yan-yan, ZHANG Wan-ying, CHENG Jie, QIU Yi-ting, WANG Xiao-lan, HUANG Wan-sha, HU Min, REN Kun, JIANG Yan1997-200113A systematic review of pharmacoeconomic studies of rare disease drugs from a societal perspectiveYANG Meng-yu, WANG Lin-ning, WANG Jia-xin, GU Xiao, GUO Xin-xin, LIU Yu-hong, SONG Yuan, LU Yun2002-201014Rapid health technology assessment of brentuximab vedotin for the treatment of relapsed or refractory Hodgkin lymphomaLIU Qian-xin, ZHANG Zhuo, ZHANG Zhi-qi, PANG Xiao-cong, ZHOU Ying2011-2016 